Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Restricted use for spinal tumour treatment:

This article was originally published in Clinica

Executive Summary

Interpore Cross International has received permission from the US FDA to sell a limited number of its expandable titanium spacers for replacing spinal segments under a humanitarian device exemption (HDE). The Telescopic Plate Spacer can be used where patients have had one of two spine vertebral bodies removed due to cancer. The Irvine, California-based company said the device is designed to allow insertion of bone graft material, adding that there are no other FDA-cleared devices that function in the same way. An HDE allows companies to market products for treating conditions that affect fewer than 4,000 people.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT075680

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel